Free Trial
Your Rate Never Goes Up! Save $100 a Year on MarketBeat All Access
Upgrade Now
Claim MarketBeat All Access Sale Promotion
NYSE:MDT

Medtronic Q2 2027 Earnings Date & Estimates

Medtronic logo
$93.61 -1.02 (-1.08%)
As of 01:35 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Medtronic is estimated to report Q2 2027 earnings on Tuesday, November 17, 2026, before market opens. The conference call is scheduled for 8:00 AM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q2 2027
Announcement Date
Time
Before Market Opens
Conference Call
8:00 AM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Medtronic in Q2 2027

Medtronic is expected to post earnings of $1.34 per share on revenue of $9.48 billion. In the same quarter a year earlier Medtronic reported $1.36 per share on revenue of $8.96 billion. Medtronic last reported on September 1, 2026, posting $1.45 per share and beating the $1.39 consensus estimate. Medtronic has beaten the consensus EPS estimate in 8 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$1.34
Expected Revenue
$9.48 billion
Prior-Year EPS
$1.36
Prior-Year Revenue
$8.96 billion
Expected EPS Growth
-1.5%
Expected Revenue Growth
+5.8%

Recent Track Record

Last Reported
Q1 2027
Last Quarter EPS
$1.45 (Beat by +$0.06)
Last Quarter Revenue
$9.76 billion
EPS Beat Rate
8 of last 8 quarters

Prepare for the Q2 2027 Call

Medtronic Q2 2027 Earnings FAQ

Medtronic (NYSE:MDT) is estimated to report Q2 2027 earnings on Tuesday, November 17, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

Medtronic's Q2 2027 earnings conference call is scheduled for Tuesday, November 17, 2026 at 8:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Medtronic to post earnings of $1.34 per share for Q2 2027.

The consensus revenue estimate for Medtronic is $9.48 billion for Q2 2027.

Medtronic Earnings Headlines

Global Medical Devices Market Size, Share, and Growth Forecast to 2031 | Aging Populations Push the Global Medical Devices Market Toward $818 Billion
 |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/global-medical-devices-market-size-090300658.html
Medtronic (MDT) Shares Moved, So What Is Driving Attention Now?
October 20 at 11:45 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/medtronic-mdt-shares-moved-driving-031909800.html
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005. Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.tc pixel
October 21 at 1:00 AM  |  The Oxford Club (Ad)
Medtronic (MDT) Sees $94.9 Million in Net ETF Selling on Oct. 16
October 20 at 8:38 AM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/medtronic-mdt-sees-94-9-110325873.html
U.S. Wireless Cardiac Monitoring Systems Market Size, Share, and Forecast 2026-2033 Featuring Profiles of Philips, iRhythm Technologies, Abbott, Medtronic, Biotronik (Teleflex) and More
October 20 at 8:38 AM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/u-wireless-cardiac-monitoring-systems-091000620.html
Medtronic (NYSE: MDT) executive sells 10,420 shares in preplanned trade
October 20 at 3:03 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31137735
See More Medtronic Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Medtronic? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Medtronic and other key companies, straight to your email.

About Medtronic

Medtronic (NYSE:MDT) (NYSE: MDT) is a global medical technology company that develops, manufactures and distributes devices and therapies used to diagnose, treat and manage a broad range of medical conditions. Its products support healthcare providers in areas including cardiac and vascular care, diabetes, neuroscience, surgical procedures and patient monitoring.

The company’s offerings include pacemakers, implantable defibrillators, heart valves and other structural heart products; insulin pumps and continuous glucose monitoring technologies; spinal and neurosurgical systems; deep-brain and spinal cord stimulation devices; surgical instruments and robotic-assisted technologies; and respiratory and patient-monitoring equipment. Medtronic also provides related software, services and solutions for hospitals and clinicians.

Medtronic was founded in 1949 and has grown into a multinational medical device company serving healthcare systems, physicians and patients in markets around the world. The company is legally headquartered in Dublin, Ireland, while its operational headquarters are in Minneapolis, Minnesota. Geoff Martha has served as Medtronic’s chairman and chief executive officer since 2020.

View Medtronic Profile
Earnings Tools